<DOC>
	<DOC>NCT02898961</DOC>
	<brief_summary>Low first-dose peak serum concentrations of amikacin and gentamicin are commonly reported in ICU patients. The present study aimed to assess whether 30 mg/kg amikacin or 8 mg/kg gentamicin achieved target concentrations in ICU patients with severe sepsis.</brief_summary>
	<brief_title>Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>ICU patient with severe sepsis Treated with aminoglycosides Renal replacement therapy Allergy to aminoglycosides Confirmed and/or suspected to have myasthenia ICUacquired neuromuscular disorder Under guardianship Prisoners The patient has already participated in the present protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>